Venture Fund Member Profile
|
 |
 |
In the MidAtlantic region, and particularly Pennsylvania, there continues to be a shortage of capital available for seed, start-up, and early stage companies that have special opportunities for exponential growth and technological innovation. And while the gap is closing in Pennsylvania and the surrounding region, capital investment at the early stage of a company's development continues to be in high demand.
New business models facilitated by breakthroughs in Information Technology and Life Sciences have led to increasing investments in start-up and early stage companies. PA Early Stage has been at the forefront of successfully accelerating this innovation cycle and closing this "capital gap" in Pennsylvania and the surrounding region by making investments in promising early stage ventures.
PA Early Stage (1) invests in early stage Information Technology and Life Sciences companies, typically as a lead investor; (2) has established a strong footprint in the corridor from New York to Washington D.C., with a primary focus on Pennsylvania; (3) is led by an investment team of business professionals with proven track records and powerful networks; (4) has a comprehensive business development methodology; and (5) provides its portfolio companies with access to growth acceleration services. Founded in 1997, PA Early Stage currently has more than 30 active portfolio companies and more than $200 million under management across three venture funds.
 |
Guy Winters, Jr.
General Counsel and Principal
PA Early Stage |
Mr. Winters joined PA Early Stage in April 2000. Mr. Winters is a licensed attorney in Pennsylvania and has practiced corporate law for over eight years. From 1994 to 1996, he worked as an associate in the Mergers and Acquisitions Department of Milbank Tweed Hadley & McCloy, New York. While at Milbank, Mr. Winters worked on a variety of large corporate transactions, including public offerings of debt and equity, mergers, acquisitions, tender offers and proxy fights.
From 1996 to April 2000, he worked as an associate in the Business and Finance Department of Morgan, Lewis & Bockius LLP, Philadelphia. While at Morgan, Lewis, Mr. Winters gained substantial experience in public offerings, mergers and acquisitions and the representation of venture capital funds. He was the lead associate on several large merger transactions, including the merger of AANetcom with PMC-Sierra, the merger of Morecom with Liberate, the merger of Safeskin with Kimberly Clark and the merger of CMAC with Amerin. Mr. Winters also represented Rohm and Haas with respect to a 144A private placement of $2 billion in debt in June 1999, Cephalon, Inc. with respect to a private placement of $125 million of equity in August 1999, Esperion Therapeutics with respect to the filing of its initial public offering in February 2000, and VerticalNet with respect to Microsoft’s $100 million investment in April 2000.
Mr. Winters is responsible for all legal-related functions at PA Early Stage, including document production and review, due diligence, deal structuring and exit strategies. He holds a BA degree from Rutgers College and a JD degree from the University of Pennsylvania School of Law. He serves on the Board of Directors of the Young Scholars Charter School.
Representative Investments
 |
MedCases, Inc. MedCases provides powerful, interactive e-learning products to healthcare organizations seeking more effective ways to use the Internet to communicate complex medical concepts and practices to physicians and other healthcare professionals. |
 |
Gazelle Systems Gazelle Systems bridges the information and access chasm between foodservice manufacturing and on-premise restaurants. With its point-of-service (POS) integration technology and a key strategic partnership, Gazelle captures and enhances customer purchase information while providing foodservice manufacturers with key restaurant purchasing. |
 |
VueSonix Sensors, Inc. VueSonix is a medical imaging company developing unique vascular imaging, diagnosis and monitoring systems using ultrasound as the enabling media. VueSonix was founded upon the recognition that current state-of-the-art devices do not adequately serve vascular markets. The company's founders are commercializing proprietary intellectual property to develop revolutionary ultrasound devices. |
 |
RealTIME Media RealTIME Media is a worldwide leader in relationship marketing utilizing the power of interactive technology. The Company helps clients acquire, activate and retain their best customers for optimum return on their investment. |
============================================
About FundingPost
For over Twelve Years FundingPost has worked with thousands
of Angel and Venture Capital Investors. We believe that it is
important to reach investors in every medium possible -
both online and offline. We have been directly responsible for
tons of success stories and Millions and Millions of dollars raised.
We look forward to introducing your company to the leading Venture and Angel Investors nationwide.
============================================
|
| Venture Fund Member Profile |
|
Bookmark to del.icio.us
Tweet this Profile
